Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

2.
3.

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, Esler MD, Dixon JB, Chopra R, Tilbrook AJ, Schlaich MP, Lambert GW.

Diabetes. 2012 Oct;61(10):2506-16. Epub 2012 Jun 4.

4.

Predictors of insulin resistance in the obese with metabolic syndrome.

Manu P, Tsang J, Napolitano BA, Lesser ML, Correll CU.

Eur J Intern Med. 2010 Oct;21(5):409-13. doi: 10.1016/j.ejim.2010.05.015. Epub 2010 Jul 1.

PMID:
20816595
5.

The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Karapanagiotidis S, Wong C, Eikelis N, Richards KL, Lee G, Nestel PJ, Dixon JB, Lambert GW, Schlaich MP, Lambert EA.

J Clin Endocrinol Metab. 2013 Feb;98(2):E227-37. doi: 10.1210/jc.2012-3277. Epub 2012 Dec 27.

PMID:
23271752
6.

Phospholipid transfer protein in diabetes, metabolic syndrome and obesity.

Qin S, Song G, Yu Y.

Cardiovasc Hematol Disord Drug Targets. 2014;14(2):149-53. Review.

PMID:
25107452
7.

Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.

Peterson RG, Jackson CV, Zimmerman K, de Winter W, Huebert N, Hansen MK.

J Diabetes Res. 2015;2015:487816. doi: 10.1155/2015/487816. Epub 2015 Apr 16.

8.

The gut-adipose-liver axis in the metabolic syndrome.

Konrad D, Wueest S.

Physiology (Bethesda). 2014 Sep;29(5):304-13. doi: 10.1152/physiol.00014.2014. Review.

PMID:
25180260
9.

The relationship between testosterone and metabolic syndrome.

Kawano H.

Hypertens Res. 2010 Jun;33(6):537-8. doi: 10.1038/hr.2010.52. Epub 2010 Apr 23. No abstract available.

PMID:
20414248
10.

Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension.

Yang M, Yang G, Dong J, Liu Y, Zong H, Liu H, Boden G, Li L.

J Investig Med. 2010 Oct;58(7):883-6. doi: 10.231/JIM.0b013e3181ec5db2.

PMID:
20601896
11.

Insulin resistance and the endothelium.

Quiñones MJ, Nicholas SB, Lyon CJ.

Curr Diab Rep. 2005 Aug;5(4):246-53. Review.

PMID:
16033673
12.

[Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].

Tobisch B, Blatniczky L, Barkai L.

Orv Hetil. 2011 Jul 3;152(27):1068-74. doi: 10.1556/OH.2011.29159. Hungarian.

PMID:
21676673
13.

Pathogenesis of the metabolic syndrome: insights from monogenic disorders.

Murphy R, Carroll RW, Krebs JD.

Mediators Inflamm. 2013;2013:920214. doi: 10.1155/2013/920214. Epub 2013 May 21. Review.

14.

The role of androgens in metabolism, obesity, and diabetes in males and females.

Navarro G, Allard C, Xu W, Mauvais-Jarvis F.

Obesity (Silver Spring). 2015 Apr;23(4):713-9. doi: 10.1002/oby.21033. Epub 2015 Mar 6. Review.

15.

Insulin action and resistance in obesity and type 2 diabetes.

Czech MP.

Nat Med. 2017 Jul 11;23(7):804-814. doi: 10.1038/nm.4350. Review.

PMID:
28697184
16.

STAMPing out Inflammation.

Waki H, Tontonoz P.

Cell. 2007 May 4;129(3):451-2.

17.

[Obesity--insulin resistance--type 2 diabetes mellitus].

Małecki MT.

Kardiol Pol. 2006 Oct;64(10 Suppl 6):S561-6. Review. Polish.

PMID:
20527377
18.

[Estrogen receptor alpha in obesity and diabetes].

Cahua-Pablo JÁ, Flores-Alfaro E, Cruz M.

Rev Med Inst Mex Seguro Soc. 2016 Jul-Aug;54(4):521-30. Review. Spanish.

PMID:
27197110
19.

Adiponectin and adiponectin receptors in obesity-linked insulin resistance.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K.

Novartis Found Symp. 2007;286:164-76; discussion 176-82, 200-3.

PMID:
18269182
20.

Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

Food Nutr Bull. 2009 Jun;30(2):161-70.

PMID:
19689095

Supplemental Content

Support Center